Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012
Florence Joly, Bénédicte Giffard, Olivier Rigal, et al.
Journal of Pain and Symptom Management (2015) Vol. 50, Iss. 6, pp. 830-841
Open Access | Times Cited: 153

Showing 51-75 of 153 citing articles:

Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results
Noemí Cerulla, Àngels Arcusa, J. Blas Navarro, et al.
Journal of Clinical and Experimental Neuropsychology (2018) Vol. 41, Iss. 3, pp. 290-299
Closed Access | Times Cited: 30
A review of cognitive screening tools in cancer
Elie Isenberg‐Grzeda, Helen Huband, Henry Lam
Current Opinion in Supportive and Palliative Care (2016) Vol. 11, Iss. 1, pp. 24-31
Closed Access | Times Cited: 29
Cognitive Impairment in Patients with Breast Cancer before Surgery: Results from a CANTO Cohort Subgroup
Marie Lange, Isabelle Hardy‐Léger, Idlir Licaj, et al.
Cancer Epidemiology Biomarkers & Prevention (2020) Vol. 29, Iss. 9, pp. 1759-1766
Open Access | Times Cited: 25
Early manifestation of mild cognitive impairment in B-cell non-Hodgkin’s lymphoma patients receiving CHOP and rituximab-CHOP chemotherapy
Mohd Ashif Khan, Kamlesh Garg, Dinesh Bhurani, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2016) Vol. 389, Iss. 12, pp. 1253-1265
Closed Access | Times Cited: 24
Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls
Annelies H. Boekhout, Anne Rogiers, Katarzyna Jóźwiak, et al.
Acta Oncologica (2020) Vol. 60, Iss. 1, pp. 69-77
Open Access | Times Cited: 23
A Prediction Model for Cognitive Impairment Risk in Colorectal Cancer after Chemotherapy Treatment
Shuping Zhou, Suding Fei, Hui-Hui Han, et al.
BioMed Research International (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 19
Tumour brain: Pretreatment cognitive and affective disorders caused by peripheral cancers
Myrthe Mampay, Melanie S. Flint, Graham K. Sheridan
British Journal of Pharmacology (2021) Vol. 178, Iss. 19, pp. 3977-3996
Open Access | Times Cited: 19
Cancer-Related Cognitive Dysfunction: A Narrative Review for Clinical Practice
Oliver Rick, Alexandra Gerhardt, Georgia Schilling
Oncology Research and Treatment (2024) Vol. 47, Iss. 5, pp. 218-223
Closed Access | Times Cited: 2
Cognitive Symptoms Across Diverse Cancers
Samantha Mayo, Kim Edelstein, Eshetu G. Atenafu, et al.
JAMA Network Open (2024) Vol. 7, Iss. 8, pp. e2430833-e2430833
Open Access | Times Cited: 2
Subjective cognitive impairment and brain structural networks in Chinese gynaecological cancer survivors compared with age-matched controls: a cross-sectional study
Yingchun Zeng, Andy S. K. Cheng, Ting Song, et al.
BMC Cancer (2017) Vol. 17, Iss. 1
Open Access | Times Cited: 23
A brief psychoeducational intervention improves memory contentment in breast cancer survivors with cognitive concerns: results of a single-arm prospective study
Lori J. Bernstein, Graham A. McCreath, Joyce Nyhof‐Young, et al.
Supportive Care in Cancer (2018) Vol. 26, Iss. 8, pp. 2851-2859
Closed Access | Times Cited: 23
Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol
Marie Lange, Heidi Solem Laviec, Hélène Castel, et al.
BMC Cancer (2017) Vol. 17, Iss. 1
Open Access | Times Cited: 22
Effects of Acupuncture on Cancer-Related Cognitive Impairment in Chinese Gynecological Cancer Patients: A Pilot Cohort Study
Yingchun Zeng, Andy S. K. Cheng, Ting Song, et al.
Integrative Cancer Therapies (2018) Vol. 17, Iss. 3, pp. 737-746
Open Access | Times Cited: 22
Impact of aerobic exercise training during chemotherapy on cancer related cognitive impairments in patients suffering from acute myeloid leukemia or myelodysplastic syndrome — Study protocol of a randomized placebo-controlled trial
Philipp Zimmer, Max Oberste, Wilhelm Bloch, et al.
Contemporary Clinical Trials (2016) Vol. 49, pp. 1-5
Closed Access | Times Cited: 20
Saikosaponin‐d impedes hippocampal neurogenesis and causes cognitive deficits by inhibiting the survival of neural stem/progenitor cells via neurotrophin receptor signaling in mice
Tingting Qin, Ziqiao Yuan, Jiayu Yu, et al.
Clinical and Translational Medicine (2020) Vol. 10, Iss. 8
Open Access | Times Cited: 19
Cognitive function in patients with chronic lymphocytic leukemia: a cross-sectional study examining effects of disease and treatment
AnnaLynn M. Williams, Edwin van Wijngaarden, Christopher L. Seplaki, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2020) Vol. 61, Iss. 7, pp. 1627-1635
Open Access | Times Cited: 18
Cognitive change in breast cancer patients up to 2 years after diagnosis
Marie Lange, Sophie Lefèvre‐Arbogast, Isabelle Hardy‐Léger, et al.
JNCI Journal of the National Cancer Institute (2022) Vol. 115, Iss. 3, pp. 322-331
Open Access | Times Cited: 11
Cancer-Induced Cognitive Impairment: Practical Solutions to Reduce and Manage the Challenge
Janette Vardy, Victoria Bray, Haryana M. Dhillon
Future Oncology (2017) Vol. 13, Iss. 9, pp. 767-771
Open Access | Times Cited: 19
Cognitive Impairment in Older Cancer Patients Treated with First-Line Chemotherapy
Mélanie Dos Santos, Idlir Licaj, C. Bellera, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6171-6171
Open Access | Times Cited: 15
Brain Hyperconnectivity >10 Years After Cisplatin-Based Chemotherapy for Testicular Cancer
Myrle M. Stouten‐Kemperman, Michiel B. de Ruiter, Willem Boogerd, et al.
Brain Connectivity (2018) Vol. 8, Iss. 7, pp. 398-406
Closed Access | Times Cited: 18
Distinct attentional function profiles in older adults receiving cancer chemotherapy
Inger Utne, Borghild Løyland, Ellen Karine Grov, et al.
European Journal of Oncology Nursing (2018) Vol. 36, pp. 32-39
Open Access | Times Cited: 17
Nicotinic treatment of post-chemotherapy subjective cognitive impairment: a pilot study
Jennifer N. Vega, Kimberly Albert, Ingrid A. Mayer, et al.
Journal of Cancer Survivorship (2019) Vol. 13, Iss. 5, pp. 673-686
Open Access | Times Cited: 16
Multimodal Web-Based Intervention for Cancer-Related Cognitive Impairment in Breast Cancer Patients: Cog-Stim Feasibility Study Protocol
Giulia Binarelli, Marie Lange, Mélanie Dos Santos, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4868-4868
Open Access | Times Cited: 14
Factors associated with cognitive impairment during the first year of treatment for nonmetastatic breast cancer
Nicole Rodriguez, Jonathan M. Fawcett, Joshua A. Rash, et al.
Cancer Medicine (2021) Vol. 10, Iss. 4, pp. 1191-1200
Open Access | Times Cited: 13
Cognitive impairment and elevated peripheral cytokines in breast cancer patients receiving chemotherapy
Mohd Ashif Khan, Dinesh Bhurani, Ubedul Hoda, et al.
Arquivos de Neuro-Psiquiatria (2022) Vol. 80, Iss. 08, pp. 786-793
Open Access | Times Cited: 9

Scroll to top